FDA declines to pull harmful Wingspan brain stents off market
The controversial Wingspan brain-stent system may remain on the market, the FDA decided last month, in spite of a well-accredited study finding that the Stryker Corp.-manufactured system might actually be detrimental to patients’ health.
The Wingspan stent is intended to physically widen brain arteries blocked by plaque, thus helping prevent stroke. But the study, which was funded by the National Institutes of Health and published in the New England Journal of Medicine, found that patients who received the device and medication were significantly more likely to suffer a stroke or die than patients who received only medication.
Following that finding, several parties requested that the FDA remove the Wingspan stent from the market. Instead, the agency merely limited the device’s use. Critics say the FDA is not making decisions in an evidence-based manner and is endangering stroke victims’ lives.
If you or a loved one has been harmed by the Wingspan stent or another dangerous medical product, contact Hodes Milman Liebeck for a free case evaluation. We’re aggressive personal injury and medical malpractice attorneys serving all of California and Arizona. We have the experience to take on the medical industry and have achieved multi-million dollar verdicts and settlements for our clients.